Evonik has posted 2013 net income of EUR2.1bn (US$2.9bn) and group sales of EUR12.9bn in what it describes as “difficult market conditions.”
The net income rose 76% to EUR2.1bn due to divestment gains from real estate activities, while adjusted EBITDA was EUR2bn.
Go deeper with GlobalData
“We have achieved our strategic objectives: Evonik is now a publicly listed speciality chemicals company,” said Evonik chairman, Klaus Engel.
“Operationally, we achieved solid results in difficult market conditions.”
For 2014 Evonik says it expects sales to rise slightly, with adjusted EBITDA estimated to be between EUR1.8bn and EUR2.1bn.
“Evonik is now listed on the stock exchange and since last summer’s divestment of the majority of shares in the real estate activities, a well-positioned and focused speciality chemicals company,” said Engel.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“In 2013 we made considerable progress with our growth strategy: The first major projects in our investment programme were completed.”
